ArticleBMJ open2020

Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy.

Wenjie Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.